Nepafenac 0.3% Two Study

NCT01318499 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1342

Enrollment

INDUSTRY

Sponsor class

Conditions

Cataract

Interventions

DRUG: Nepafenac Ophthalmic Suspension, 0.3%
DRUG: Nepafenac Ophthalmic Suspension, 0.1%
OTHER: Nepafenac Vehicle 0.3%

Sponsor

Alcon Research